JP2019500899A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019500899A5 JP2019500899A5 JP2018545579A JP2018545579A JP2019500899A5 JP 2019500899 A5 JP2019500899 A5 JP 2019500899A5 JP 2018545579 A JP2018545579 A JP 2018545579A JP 2018545579 A JP2018545579 A JP 2018545579A JP 2019500899 A5 JP2019500899 A5 JP 2019500899A5
- Authority
- JP
- Japan
- Prior art keywords
- rna
- polypeptide
- nucleoprotein complex
- polynucleotide
- nuclease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022023996A JP2022081503A (ja) | 2015-11-23 | 2022-02-18 | ＣＲＩＳＰＲ／Ｃａｓ９の核送達を通じた細胞ＲＮＡの追跡と操作 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562259014P | 2015-11-23 | 2015-11-23 | |
| US62/259,014 | 2015-11-23 | ||
| PCT/US2016/063429 WO2017091630A1 (en) | 2015-11-23 | 2016-11-22 | Tracking and manipulating cellular rna via nuclear delivery of crispr/cas9 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022023996A Division JP2022081503A (ja) | 2015-11-23 | 2022-02-18 | ＣＲＩＳＰＲ／Ｃａｓ９の核送達を通じた細胞ＲＮＡの追跡と操作 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019500899A JP2019500899A (ja) | 2019-01-17 |
| JP2019500899A5 true JP2019500899A5 (https=) | 2020-05-28 |
Family
ID=57750540
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018545579A Pending JP2019500899A (ja) | 2015-11-23 | 2016-11-22 | ＣＲＩＳＰＲ／Ｃａｓ９の核送達を通じた細胞ＲＮＡの追跡と操作 |
| JP2022023996A Pending JP2022081503A (ja) | 2015-11-23 | 2022-02-18 | ＣＲＩＳＰＲ／Ｃａｓ９の核送達を通じた細胞ＲＮＡの追跡と操作 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022023996A Pending JP2022081503A (ja) | 2015-11-23 | 2022-02-18 | ＣＲＩＳＰＲ／Ｃａｓ９の核送達を通じた細胞ＲＮＡの追跡と操作 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20170145394A1 (https=) |
| EP (2) | EP4163374A1 (https=) |
| JP (2) | JP2019500899A (https=) |
| CN (1) | CN109072235B (https=) |
| AU (1) | AU2016359629B2 (https=) |
| CA (1) | CA3005968A1 (https=) |
| ES (1) | ES2930643T3 (https=) |
| PT (1) | PT3380613T (https=) |
| SG (2) | SG11201804372PA (https=) |
| WO (1) | WO2017091630A1 (https=) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
| WO2017004261A1 (en) | 2015-06-29 | 2017-01-05 | Ionis Pharmaceuticals, Inc. | Modified crispr rna and modified single crispr rna and uses thereof |
| IL310721B2 (en) | 2015-10-23 | 2025-11-01 | Harvard College | Nucleobase editors and uses thereof |
| CA3005968A1 (en) | 2015-11-23 | 2017-06-01 | The Regents Of The University Of California | Tracking and manipulating cellular rna via nuclear delivery of crispr/cas9 |
| CN110214183A (zh) | 2016-08-03 | 2019-09-06 | 哈佛大学的校长及成员们 | 腺苷核碱基编辑器及其用途 |
| WO2018031683A1 (en) | 2016-08-09 | 2018-02-15 | President And Fellows Of Harvard College | Programmable cas9-recombinase fusion proteins and uses thereof |
| US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| KR102622411B1 (ko) | 2016-10-14 | 2024-01-10 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| US12390514B2 (en) | 2017-03-09 | 2025-08-19 | President And Fellows Of Harvard College | Cancer vaccine |
| US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
| KR20240116572A (ko) | 2017-03-23 | 2024-07-29 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제 |
| WO2018208998A1 (en) | 2017-05-10 | 2018-11-15 | The Regents Of The University Of California | Directed editing of cellular rna via nuclear delivery of crispr/cas9 |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| WO2018232356A1 (en) | 2017-06-15 | 2018-12-20 | The Regents Of The University Of California | Targeted non-viral dna insertions |
| CN111801345A (zh) | 2017-07-28 | 2020-10-20 | 哈佛大学的校长及成员们 | 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物 |
| US11970720B2 (en) | 2017-08-22 | 2024-04-30 | Salk Institute For Biological Studies | RNA targeting methods and compositions |
| US10476825B2 (en) | 2017-08-22 | 2019-11-12 | Salk Institue for Biological Studies | RNA targeting methods and compositions |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| KR20250107288A (ko) | 2017-10-16 | 2025-07-11 | 더 브로드 인스티튜트, 인코퍼레이티드 | 아데노신 염기 편집제의 용도 |
| WO2019084140A1 (en) * | 2017-10-24 | 2019-05-02 | Sangamo Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RARE DISEASES |
| JP7101419B2 (ja) | 2017-10-27 | 2022-07-15 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 内因性ｔ細胞受容体の標的置換 |
| CN107893260B (zh) * | 2017-11-27 | 2021-01-12 | 广州市锐博生物科技有限公司 | 高效去除核糖体rna的构建转录组测序文库的方法及试剂盒 |
| CN108103090B (zh) * | 2017-12-12 | 2021-06-15 | 中山大学附属第一医院 | 靶向RNA甲基化的RNA Cas9-m6A修饰载体系统及其构建方法和应用 |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| CN108559760A (zh) * | 2018-01-09 | 2018-09-21 | 陕西师范大学 | 基于CRISPR靶向基因组修饰技术建立荧光素酶knock-in细胞系的方法 |
| WO2019178428A1 (en) * | 2018-03-14 | 2019-09-19 | Arbor Biotechnologies, Inc. | Novel crispr dna and rna targeting enzymes and systems |
| WO2019178427A1 (en) | 2018-03-14 | 2019-09-19 | Arbor Biotechnologies, Inc. | Novel crispr dna targeting enzymes and systems |
| WO2019222437A1 (en) * | 2018-05-15 | 2019-11-21 | The Children's Hospital Of Philadelphia | Crispr interference based htt allelic suppression and treatment of huntington disease |
| WO2019222555A1 (en) | 2018-05-16 | 2019-11-21 | Arbor Biotechnologies, Inc. | Novel crispr-associated systems and components |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| EP3575401A1 (en) * | 2018-05-29 | 2019-12-04 | Ecole Polytechnique Federale De Lausanne (Epfl) | Methods of treating or preventing an aging-related disease |
| KR20210058806A (ko) | 2018-06-08 | 2021-05-24 | 로카나바이오 인크. | Rna 표적화 융합 단백질 조성물 및 사용 방법 |
| SG11202012015YA (en) * | 2018-06-08 | 2021-01-28 | Locanabio Inc | Compositions and methods for the modulation of adaptive immunity |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| JP2021531038A (ja) | 2018-07-13 | 2021-11-18 | ザ、トラスティーズ オブ プリンストン ユニバーシティ | ストレス顆粒集合を調節するためのシステム及び方法 |
| US20210388351A1 (en) * | 2018-09-28 | 2021-12-16 | The Jackson Laboratory | Artificial rna-guided splicing factors |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| CN109706149B (zh) * | 2018-11-29 | 2020-12-18 | 华中农业大学 | 一种改进的16S-seq方法及其应用 |
| RU2694396C1 (ru) * | 2018-12-14 | 2019-07-12 | Федеральное Бюджетное Учреждение Науки "Центральный Научно-Исследовательский Институт Эпидемиологии" Федеральной Службы По Надзору В Сфере Защиты Прав Потребителей И Благополучия Человека | РНК-проводник St10 для использования в высокоспецифической системе нуклеаз Streptococcus thermophilus CRISPR/Cas9 (StCas9) и применение указанного РНК-проводника и белка StCas9 для подавления экспрессии вируса гепатита B в клетке-хозяине и для элиминации вирусной ДНК из клетки-хозяина |
| AU2020208346B2 (en) * | 2019-01-14 | 2026-01-29 | University Of Rochester | Targeted nuclear RNA cleavage and polyadenylation with CRISPR-cas |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| US20220249625A1 (en) * | 2019-01-29 | 2022-08-11 | Flagship Pioneering Innovations V, Inc. | Compositions comprising an endonuclease and methods for purifying an endonuclease |
| LU101118B1 (en) | 2019-02-06 | 2020-08-06 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Method for detecting a specific splice event of a gene of interest |
| CN109811072B (zh) * | 2019-02-28 | 2022-05-06 | 广州微远医疗器械有限公司 | 用于结核分枝杆菌复合群的crispr检测引物组及其用途 |
| WO2020191233A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| CN110004181B (zh) * | 2019-03-20 | 2022-10-11 | 东北农业大学 | 一种附加型CRISPR/Cas9表达载体及其构建方法与应用 |
| WO2020198640A1 (en) * | 2019-03-27 | 2020-10-01 | Massachusetts Institute Of Technology | Programmable imaging methods and compositions |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| TW202521561A (zh) | 2019-04-23 | 2025-06-01 | 美商聖加莫治療股份有限公司 | 染色體9開放讀框72基因表現之調節子及其用途 |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| CN110714008A (zh) * | 2019-10-17 | 2020-01-21 | 南通大学 | 核苷酸序列构建的crispr重组质粒靶向编辑iss序列的方法 |
| WO2021111466A1 (en) * | 2019-12-02 | 2021-06-10 | Council Of Scientific & Industrial Research | Method and kit for detection of polynucleotide |
| IL297761A (en) | 2020-05-08 | 2022-12-01 | Broad Inst Inc | Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence |
| US12139710B2 (en) | 2020-10-28 | 2024-11-12 | The Regents Of The University Of California | Methods of modulating RNA translation |
| GB202105455D0 (en) | 2021-04-16 | 2021-06-02 | Ucl Business Ltd | Composition |
| EP4095243A1 (en) * | 2021-05-25 | 2022-11-30 | European Molecular Biology Laboratory | System for hybridization-based precision genome cleavage and editing, and uses thereof |
| US11795500B2 (en) | 2021-08-19 | 2023-10-24 | Eclipse Bioinnovations, Inc. | Methods for detecting RNA binding protein complexes |
| AU2022337146A1 (en) | 2021-09-03 | 2024-03-14 | Tacit Therapeutics, Inc. | Rna editing via recruitment of spliceosome components |
| JP2024537991A (ja) | 2021-10-14 | 2024-10-18 | アーセナル バイオサイエンシズ インコーポレイテッド | 共発現されるｓｈＲＮＡと論理ゲートシステムとを有する免疫細胞 |
| WO2023129973A2 (en) * | 2021-12-30 | 2023-07-06 | Eclipse Bioinnovations, Inc. | Methods for detecting rna modification targets on a gene |
| WO2023205637A1 (en) * | 2022-04-18 | 2023-10-26 | Locanabio, Inc. | Rna-targeting compositions and methods for treating c9/orf72 diseases |
| CN115044620B (zh) * | 2022-06-30 | 2024-01-05 | 上海海洋大学 | 微卫星重复序列敲除突变体的构建方法和应用 |
| CN115927425B (zh) * | 2022-07-14 | 2025-03-25 | 华中农业大学 | 一种嗜热栖热菌基因编辑质粒及在生产超氧化物歧化酶中的应用 |
| AU2024270764A1 (en) | 2023-05-15 | 2025-12-04 | Nchroma Bio, Inc. | Compositions and methods for epigenetic regulation of hbv gene expression |
| CN117925787A (zh) * | 2024-01-17 | 2024-04-26 | 北京医院 | 基于“内-外”双重信号放大的DCasFISH染色体多色原位成像系统 |
| CN121380070B (zh) * | 2025-11-10 | 2026-04-10 | 上海交通大学医学院附属仁济医院 | 靶向sfpq的腺相关病毒及其在制备治疗神经母细胞瘤的药物中的用途 |
Family Cites Families (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3687808A (en) | 1969-08-14 | 1972-08-29 | Univ Leland Stanford Junior | Synthetic polynucleotides |
| US5405938A (en) | 1989-12-20 | 1995-04-11 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
| US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5166315A (en) | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
| US5216141A (en) | 1988-06-06 | 1993-06-01 | Benner Steven A | Oligonucleotide analogs containing sulfur linkages |
| US5264562A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences, Inc. | Oligonucleotide analogs with novel linkages |
| US5264564A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences | Oligonucleotide analogs with novel linkages |
| US5470967A (en) | 1990-04-10 | 1995-11-28 | The Dupont Merck Pharmaceutical Company | Oligonucleotide analogs with sulfamate linkages |
| US5541307A (en) | 1990-07-27 | 1996-07-30 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs and solid phase synthesis thereof |
| US5608046A (en) | 1990-07-27 | 1997-03-04 | Isis Pharmaceuticals, Inc. | Conjugated 4'-desmethyl nucleoside analog compounds |
| US5610289A (en) | 1990-07-27 | 1997-03-11 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogues |
| US5489677A (en) | 1990-07-27 | 1996-02-06 | Isis Pharmaceuticals, Inc. | Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms |
| US5677437A (en) | 1990-07-27 | 1997-10-14 | Isis Pharmaceuticals, Inc. | Heteroatomic oligonucleoside linkages |
| US5618704A (en) | 1990-07-27 | 1997-04-08 | Isis Pharmacueticals, Inc. | Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling |
| US5623070A (en) | 1990-07-27 | 1997-04-22 | Isis Pharmaceuticals, Inc. | Heteroatomic oligonucleoside linkages |
| US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
| MY107332A (en) | 1990-08-03 | 1995-11-30 | Sterling Drug Inc | Compounds and methods for inhibiting gene expression. |
| US5214134A (en) | 1990-09-12 | 1993-05-25 | Sterling Winthrop Inc. | Process of linking nucleosides with a siloxane bridge |
| US5561225A (en) | 1990-09-19 | 1996-10-01 | Southern Research Institute | Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages |
| JPH06505704A (ja) | 1990-09-20 | 1994-06-30 | ギリアド サイエンシズ，インコーポレイテッド | 改変ヌクレオシド間結合 |
| US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| US5719262A (en) | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
| US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
| US5633360A (en) | 1992-04-14 | 1997-05-27 | Gilead Sciences, Inc. | Oligonucleotide analogs capable of passive cell membrane permeation |
| US5434257A (en) | 1992-06-01 | 1995-07-18 | Gilead Sciences, Inc. | Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages |
| GB9304618D0 (en) | 1993-03-06 | 1993-04-21 | Ciba Geigy Ag | Chemical compounds |
| HU9501974D0 (en) | 1993-03-31 | 1995-09-28 | Sterling Winthrop Inc | Oligonucleotides with amide linkages replacing phosphodiester linkages |
| DE19502912A1 (de) | 1995-01-31 | 1996-08-01 | Hoechst Ag | G-Cap Stabilisierte Oligonucleotide |
| US6042820A (en) | 1996-12-20 | 2000-03-28 | Connaught Laboratories Limited | Biodegradable copolymer containing α-hydroxy acid and α-amino acid units |
| JP3756313B2 (ja) | 1997-03-07 | 2006-03-15 | 武 今西 | 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体 |
| JP4236812B2 (ja) | 1997-09-12 | 2009-03-11 | エクシコン エ／エス | オリゴヌクレオチド類似体 |
| DE69940196D1 (de) | 1998-04-15 | 2009-02-12 | Hutchinson Fred Cancer Res | Methoden und vektorenkonstrukte zur erzeugung von transgene nagetieren, welche ein heterologes gen ubiquitär exprimieren |
| US6472375B1 (en) | 1998-04-16 | 2002-10-29 | John Wayne Cancer Institute | DNA vaccine and methods for its use |
| US7078387B1 (en) | 1998-12-28 | 2006-07-18 | Arch Development Corp. | Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| US7053207B2 (en) | 1999-05-04 | 2006-05-30 | Exiqon A/S | L-ribo-LNA analogues |
| IL149694A0 (en) | 1999-12-23 | 2002-11-10 | Exiqon As | Therapeutic uses of lna-modified oligonucleotides |
| CA2402452A1 (en) | 2000-03-31 | 2001-10-11 | Cambridge Antibody Technology Limited | Improvements to ribosome display |
| EP2500427B1 (en) | 2007-11-22 | 2014-07-30 | Japan Science and Technology Agency | Translation regulation system in cell or artifical cell model by using low-molecular-weight RNA |
| WO2012068627A1 (en) | 2010-11-24 | 2012-05-31 | The University Of Western Australia | Peptides for the specific binding of rna targets |
| JPWO2012093422A1 (ja) | 2011-01-07 | 2014-06-09 | 坂東機工株式会社 | 炭化珪素板のスクライブ方法及びスクライブ装置 |
| DK2784157T3 (da) | 2011-10-21 | 2019-10-21 | Univ Kyushu Nat Univ Corp | Designfremgangsmåde til et rna-bindende protein under anvendelse af ppr-motiv og anvendelse deraf |
| US10066228B2 (en) | 2011-11-30 | 2018-09-04 | Sarepta Therapeutics, Inc. | Oligonucleotides for treating expanded repeat diseases |
| JP6355563B2 (ja) | 2012-02-27 | 2018-07-11 | アムニクス オペレーティング インコーポレイテッド | Ｘｔｅｎ共役組成物およびそれを製造する方法 |
| EP3031921B1 (en) | 2012-12-12 | 2025-03-12 | The Broad Institute, Inc. | Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications |
| CN113355357B (zh) * | 2012-12-12 | 2024-12-03 | 布罗德研究所有限公司 | 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化 |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| CA2898184A1 (en) * | 2013-01-16 | 2014-07-24 | Emory University | Cas9-nucleic acid complexes and uses related thereto |
| TWI484033B (zh) | 2013-01-25 | 2015-05-11 | Univ China Medical | 培養幹細胞之方法及套組 |
| CN105683376A (zh) * | 2013-05-15 | 2016-06-15 | 桑格摩生物科学股份有限公司 | 用于治疗遗传病状的方法和组合物 |
| EP3004339B1 (en) * | 2013-05-29 | 2021-07-07 | Cellectis | New compact scaffold of cas9 in the type ii crispr system |
| AU2014273082B2 (en) * | 2013-05-29 | 2018-11-08 | Cellectis | A method for producing precise DNA cleavage using Cas9 nickase activity |
| EP3666892A1 (en) * | 2013-07-10 | 2020-06-17 | President and Fellows of Harvard College | Orthogonal cas9 proteins for rna-guided gene regulation and editing |
| CA2921556A1 (en) | 2013-08-16 | 2015-02-19 | Rana Therapeutics, Inc. | Compositions and methods for modulating rna |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| WO2015048690A1 (en) * | 2013-09-27 | 2015-04-02 | The Regents Of The University Of California | Optimized small guide rnas and methods of use |
| US9074199B1 (en) | 2013-11-19 | 2015-07-07 | President And Fellows Of Harvard College | Mutant Cas9 proteins |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| EP3835419A1 (en) | 2013-12-12 | 2021-06-16 | The Regents of The University of California | Methods and compositions for modifying a single stranded target nucleic acid |
| JP6712948B2 (ja) | 2013-12-12 | 2020-06-24 | ザ・ブロード・インスティテュート・インコーポレイテッド | 組成物、及びヌクレオチドリピート障害におけるｃｒｉｓｐｒ−ｃａｓ系の使用方法 |
| EP3115457B1 (en) | 2014-03-05 | 2019-10-02 | National University Corporation Kobe University | Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same |
| CN105338513B (zh) | 2014-08-08 | 2019-12-10 | 中兴通讯股份有限公司 | 设备到设备业务处理方法及装置 |
| EP3234134B1 (en) | 2014-12-17 | 2020-05-27 | ProQR Therapeutics II B.V. | Targeted rna editing |
| WO2016106236A1 (en) * | 2014-12-23 | 2016-06-30 | The Broad Institute Inc. | Rna-targeting system |
| US10330674B2 (en) | 2015-01-13 | 2019-06-25 | Massachusetts Institute Of Technology | Pumilio domain-based modular protein architecture for RNA binding |
| WO2016183402A2 (en) | 2015-05-13 | 2016-11-17 | President And Fellows Of Harvard College | Methods of making and using guide rna for use with cas9 systems |
| WO2016191684A1 (en) | 2015-05-28 | 2016-12-01 | Finer Mitchell H | Genome editing vectors |
| WO2016196655A1 (en) | 2015-06-03 | 2016-12-08 | The Regents Of The University Of California | Cas9 variants and methods of use thereof |
| CA3001683C (en) | 2015-06-05 | 2024-06-04 | The Regents Of The University Of California | Methods and compositions for generating crispr/cas guide rnas |
| US20160362667A1 (en) | 2015-06-10 | 2016-12-15 | Caribou Biosciences, Inc. | CRISPR-Cas Compositions and Methods |
| US20180142222A1 (en) | 2015-06-12 | 2018-05-24 | The Regents Of The University Of California | Reporter cas9 variants and methods of use thereof |
| EP3323890A4 (en) | 2015-07-14 | 2019-01-30 | Fukuoka University | METHOD OF INDUSTRYING SITE-SPECIFIC RNA MUTATIONS, TARGETED EDITING GUIDE RNA USED IN THE METHOD AND TARGET RNA TARGET EDITING GUIDE RNA COMPLEX |
| CN120842296A (zh) | 2015-09-21 | 2025-10-28 | 垂林克生物技术有限公司 | 用于合成5’-加帽rna的组合物和方法 |
| US20180237800A1 (en) | 2015-09-21 | 2018-08-23 | The Regents Of The University Of California | Compositions and methods for target nucleic acid modification |
| CA3005968A1 (en) * | 2015-11-23 | 2017-06-01 | The Regents Of The University Of California | Tracking and manipulating cellular rna via nuclear delivery of crispr/cas9 |
| CN109642231A (zh) | 2016-06-17 | 2019-04-16 | 博德研究所 | Vi型crispr直向同源物和系统 |
| LT6525B (lt) | 2016-06-29 | 2018-05-10 | Uab Pixpro | Skaitmeninių vaizdų skyros didinimo būdas taikant unikalų dalinai persidengiančių mažos skyros vaizdų apdorojimą |
| CN110214183A (zh) | 2016-08-03 | 2019-09-06 | 哈佛大学的校长及成员们 | 腺苷核碱基编辑器及其用途 |
| EP3585895A1 (en) | 2017-02-22 | 2020-01-01 | CRISPR Therapeutics AG | Compositions and methods for gene editing |
| EP3600027B1 (en) | 2017-03-31 | 2026-02-18 | Neurodiagnostics LLC | Lymphocyte-based morphometric test for alzheimer's disease |
| WO2018208998A1 (en) | 2017-05-10 | 2018-11-15 | The Regents Of The University Of California | Directed editing of cellular rna via nuclear delivery of crispr/cas9 |
| US10392616B2 (en) | 2017-06-30 | 2019-08-27 | Arbor Biotechnologies, Inc. | CRISPR RNA targeting enzymes and systems and uses thereof |
| US10476825B2 (en) | 2017-08-22 | 2019-11-12 | Salk Institue for Biological Studies | RNA targeting methods and compositions |
| AU2018338318B2 (en) | 2017-09-21 | 2022-12-22 | Massachusetts Institute Of Technology | Systems, methods, and compositions for targeted nucleic acid editing |
| CN108103090B (zh) | 2017-12-12 | 2021-06-15 | 中山大学附属第一医院 | 靶向RNA甲基化的RNA Cas9-m6A修饰载体系统及其构建方法和应用 |
| US20210079366A1 (en) | 2017-12-22 | 2021-03-18 | The Broad Institute, Inc. | Cas12a systems, methods, and compositions for targeted rna base editing |
| CA3097857A1 (en) | 2018-04-20 | 2019-10-24 | The Regents Of The University Of California | Fusion proteins and fusion ribonucleic acids for tracking and manipulating cellular rna |
| WO2020047498A1 (en) | 2018-08-31 | 2020-03-05 | The Regents Of The University Of California | Directed modification of rna |
| WO2020047489A1 (en) | 2018-08-31 | 2020-03-05 | The Regents Of The University Of California | Directed pseudouridylation of rna |
| CN110055284A (zh) | 2019-04-15 | 2019-07-26 | 中山大学 | 一种基于PspCas13b-Alkbh5单基因特异性m6A修饰编辑方法 |
| US20220204978A1 (en) | 2019-04-16 | 2022-06-30 | The Regents Of The University Of California | Protein translational control |
-
2016
- 2016-11-22 CA CA3005968A patent/CA3005968A1/en active Pending
- 2016-11-22 AU AU2016359629A patent/AU2016359629B2/en active Active
- 2016-11-22 EP EP22195456.3A patent/EP4163374A1/en active Pending
- 2016-11-22 SG SG11201804372PA patent/SG11201804372PA/en unknown
- 2016-11-22 SG SG10202004557QA patent/SG10202004557QA/en unknown
- 2016-11-22 CN CN201680079817.XA patent/CN109072235B/zh active Active
- 2016-11-22 ES ES16822766T patent/ES2930643T3/es active Active
- 2016-11-22 WO PCT/US2016/063429 patent/WO2017091630A1/en not_active Ceased
- 2016-11-22 PT PT168227668T patent/PT3380613T/pt unknown
- 2016-11-22 US US15/359,567 patent/US20170145394A1/en not_active Abandoned
- 2016-11-22 JP JP2018545579A patent/JP2019500899A/ja active Pending
- 2016-11-22 EP EP16822766.8A patent/EP3380613B1/en active Active
-
2018
- 2018-08-03 US US16/054,298 patent/US20190040370A1/en not_active Abandoned
-
2020
- 2020-02-19 US US16/794,918 patent/US11667903B2/en active Active
-
2022
- 2022-02-18 JP JP2022023996A patent/JP2022081503A/ja active Pending
-
2023
- 2023-04-25 US US18/306,673 patent/US20230365951A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019500899A5 (https=) | ||
| AU2022250450B2 (en) | RNA-guided gene editing and gene regulation | |
| US20230279391A1 (en) | Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste) | |
| US12214054B2 (en) | Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use | |
| AU2020257898B2 (en) | AAV vector-mediated deletion of large mutational hotspot for treatment of duchenne muscular dystrophy | |
| JP7827288B2 (ja) | ジストロフィン機能を修復するためのＣＲＩＳＰＲ／Ｃａｓをベースにしたゲノム編集組成物 | |
| JP2022153386A (ja) | Ｃｐｆ１に基づくゲノム編集の治療適用 | |
| JP4063319B2 (ja) | 組換えウイルスベクター系 | |
| US20190134221A1 (en) | Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy | |
| US20240026352A1 (en) | Targeted gene regulation of human immune cells with crispr-cas systems | |
| WO2019209914A2 (en) | Homology-directed repair template design and delivery to edit hemoglobin-related mutations | |
| US20230392132A1 (en) | Dual aav vector-mediated deletion of large mutational hotspot for treatment of duchenne muscular dystrophy | |
| CN112930395A (zh) | 靶向rna的融合蛋白组合物和使用方法 | |
| JP2019524140A5 (https=) | ||
| JP2023515710A (ja) | ＣＲＩＳＰＲ媒介式エクソン欠失用の最適なｇＲＮＡ対を発見するためのハイスループットスクリーニング法 | |
| WO2024081937A2 (en) | Cas12a fusion proteins and methods of using same | |
| WO2023200998A2 (en) | Effector domains for crispr-cas systems | |
| Barth et al. | Regulation of two nested proteins from gene 49 (recombination endonuclease VII) and of a lambda RexA-like protein of bacteriophage T4. | |
| US20250171754A1 (en) | Crispr-cas9 compositions and methods with a novel cas9 protein for genome editing and gene regulation | |
| US20230287441A1 (en) | Programmable insertion approaches via reverse transcriptase recruitment | |
| JP2017531432A (ja) | バクテリオファージの改変 | |
| KR20190037167A (ko) | 혈액응고인자 viii 유전자 역위 보정능의 유전자 가위 시스템으로 구성된 혈우병 치료용 조성물 | |
| De Angeli | Rescue of Missplicing by CRISPR/SpCas9-Based Genome Editing Approaches Targeting Deep-Intronic Variants in ABCA4 | |
| Zhang et al. | Defect-complementation homologous recombination: A novel strategy for precise genome engineering of virulent phages | |
| HK40126455A (zh) | Rna指导的基因编辑和基因调节 |